A HIGHLY EFFICIENT SYNTHESIS OF RWJ-47639 - A NOVEL, ORALLY-ACTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST

被引:3
|
作者
HSI, JD
MURRAY, WV
GILL, A
机构
关键词
D O I
10.1016/S0960-894X(00)80010-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
RWJ 47639 (1), a new, potent and orally active angiotensin II receptor antagonist was synthesized by an efficient three-step process utilizing addition of a substituted phenyllithium to an ortho-fluorophenyloxazoline as the key step.
引用
收藏
页码:1523 / 1526
页数:4
相关论文
共 50 条
  • [41] N-0840 - A NOVEL, NONXANTHINE, ORALLY-ACTIVE, SELECTIVE ADENOSINE-A1-RECEPTOR ANTAGONIST
    BARRETT, RJ
    WRIGHT, KF
    DROPPLEMAN, DA
    FASEB JOURNAL, 1992, 6 (04): : A1008 - A1008
  • [42] Efficient synthesis of valsartan, a nonpeptide angiotensin II receptor antagonist
    Zhang, C
    Zheng, GJ
    Fang, LJ
    Li, YL
    SYNLETT, 2006, (03) : 475 - 477
  • [43] DESIGN, SYNTHESIS AND EVALUATION OF THE POTENT, ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST L-734,217
    DUGGAN, ME
    NAYLOROLSEN, AM
    PERKINS, JJ
    ANDERSON, PS
    CHANG, CTC
    COOK, JJ
    GOULD, RJ
    IHLE, NC
    HARTMAN, GD
    LYNCH, JJ
    LYNCH, RJ
    MANNO, PD
    SCHAFFER, LW
    SMITH, RL
    BEDNAR, B
    BEDNAR, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1995, 210 : 2 - MEDI
  • [44] PHARMACOLOGY OF CS-866, A NOVEL NONPEPTIDE ANGIOTENSIN-II RECEPTOR ANTAGONIST
    MIZUNO, M
    SADA, T
    IKEDA, M
    FUKUDA, N
    MIYAMOTO, M
    YANAGISAWA, H
    KOIKE, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 285 (02) : 181 - 188
  • [45] PHARMACOLOGICAL PROFILE OF ME3221, A NOVEL ANGIOTENSIN-II RECEPTOR ANTAGONIST
    NAGURA, J
    YASUDA, S
    FUJISHIMA, K
    YAMAMOTO, M
    HUI, C
    KAWANO, KI
    KATANO, K
    OGINO, H
    HACHISU, M
    KONNO, F
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 274 (1-3) : 201 - 211
  • [46] Synthesis of a novel angiotensin II receptor antagonist olmesartan medoxomil
    Yu, Xin-Hong
    Tang, Jian
    Wen, Xin-Min
    Mao, Qing-Hua
    Shen, Yong-Jia
    Huadong Ligong Daxue Xuebao /Journal of East China University of Science and Technology, 2005, 31 (02): : 189 - 192
  • [47] ENDOGENOUS ANGIOTENSIN-II REGULATES LV CONTRACTILITY INVIVO - A STUDY USING DUP753, A NOVEL ANGIOTENSIN-II RECEPTOR ANTAGONIST
    MOSCUCCI, M
    MARCUS, R
    KORCARZ, C
    OSINSKI, J
    MURPHY, M
    LANG, R
    CLINICAL RESEARCH, 1991, 39 (03): : A693 - A693
  • [48] Acyliminothiadiazoline derivatives: New, highly potent, and orally active angiotensin II receptor antagonists
    Hirata, T
    Nomiyama, J
    Sakae, N
    Nishimura, K
    Yokomoto, M
    Inoue, S
    Tamura, K
    Okuhira, M
    Amano, H
    Nagao, Y
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (13) : 1469 - 1474
  • [49] Design and Synthesis of Selurampanel, a Novel Orally Active and Competitive AMPA Receptor Antagonist
    Orain, David
    Tasdelen, Engin
    Haessig, Samuel
    Koller, Manuel
    Picard, Anne
    Dubois, Celine
    Lingenhoehl, Kurt
    Desrayaud, Sandrine
    Floersheim, Phillip
    Carcache, David
    Urwyler, Stephan
    Kallen, Joerg
    Mattes, Henri
    CHEMMEDCHEM, 2017, 12 (03) : 197 - 201
  • [50] CHARACTERIZATION OF A NOVEL NONPEPTIDE ANGIOTENSIN-II (AII) RECEPTOR ANTAGONIST, SC-52458
    OLINS, GM
    CORPUS, VM
    CHEN, ST
    MCMAHON, EG
    PALOMO, MA
    MCGRAW, DE
    NULL, CL
    BITTNER, SE
    SMITS, GJ
    KOEPKE, JP
    BLEHM, DJ
    SCHUH, JR
    REITZ, DB
    PENICK, MA
    MANNING, RE
    BLAINE, EH
    FASEB JOURNAL, 1993, 7 (04): : A654 - A654